CL King Initiates Coverage On Boston Scientific with Buy Rating, Announces Price Target of $64
Portfolio Pulse from richadhand@benzinga.com
CL King analyst Kristen Stewart has initiated coverage on Boston Scientific (NYSE:BSX) with a Buy rating and a price target of $64.
June 30, 2023 | 12:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific has been initiated with a Buy rating by CL King, with a price target of $64.
The initiation of coverage by CL King with a Buy rating indicates a positive outlook for Boston Scientific. The price target of $64 suggests a potential upside from the current trading price. This could lead to increased investor interest and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100